![Bulk Human IgG4 Isotype Control S228P (IB4) [ICH2257S228P]](https://cdn11.bigcommerce.com/s-ljfuczbkhb/images/stencil/1200x1200/products/379/562/Untitled_design__06827.1699286219.png?c=1 "Bulk Human IgG4 Isotype Control S228P (IB4) [ICH2257S228P]")
![Theralizumab Biosimilar - Research Grade [ICH5023]](https://cdn11.bigcommerce.com/s-ljfuczbkhb/images/stencil/1200x1200/products/299/641/Untitled_design__28262.1699286219.png?c=1 "Theralizumab Biosimilar - Research Grade [ICH5023]")
![Ado-trastuzumab emtansine Biosimilar - Research Grade [ICH4014]](https://cdn11.bigcommerce.com/s-ljfuczbkhb/images/stencil/1200x1200/products/166/1022/ICH4014_Ado-trastuzumab-emtansine__98698.1699286215.jpg?c=1 "Ado-trastuzumab emtansine Biosimilar - Research Grade [ICH4014]")
Making cancer research faster and more cost effective.
Delivering research biosimilars at a faster rate to allow you to iterate your experiments quicker.
IHC1132 Xu et al. (bioRxiv)
ICH5015 Lee et al. (Journal of Experimental & Clinical Cancer Research)
ICH2248 Travelli et al. (Journal for ImmunoTheraphy of Cancer)
ICH4011, ICH4009, ICH4019 Narsimhan et al. (Analytical Chemistry)
ICH1077, ICH1042, ICH1043 Cao et al. (Journal of Nanobiotechnology )
ICH1128UL Yang et al. (Journal of Integrative Medicine)
ICH1026 Yuan et al. (Cytokine)
ICH1073 Pircher et al. (European Journal of Immunology)
ICH1086 Chen et al. (Advanced Science)
ICH1086, ICH2243 Majewska et al. (bioRxiv)
At the coalface of I-O research - biosimilars, bispecifics, ADCs, in vivo antibodies and isotype controls.
Supporting you in producing the next great oncology breakthrough
7th Nov 2023
2nd Nov 2023
25th Oct 2023
4th Oct 2023
4th Oct 2023
20th Sep 2023
19th Sep 2023
13th Sep 2023
6th Sep 2023
9th Aug 2023
